Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT04031118Not ApplicableCompleted

Corneal Oxygen Uptake With Apioc Contact Lenses

Role: lead

NCT04437732Not ApplicableCompleted

Apioc Presbyopic Contact Lens

Role: lead

NCT04883099Not ApplicableCompleted

APIOC for Presbyopia and APIOC for Presbyopia With Astigmatism

Role: lead

NCT03970512Not ApplicableCompleted

Apioc Toric/Spherical Single Vision Contact Lens

Role: lead

NCT03688672Not ApplicableCompleted

Apioc Contact Lens Feasibility

Role: lead

NCT04806802Not ApplicableCompleted

APIOC Sphere and APIOC Astigmatism

Role: lead

All 6 trials loaded